Patents
Patents for C07C 43 - Ethers; Compounds having groups, groups or groups (24,599)
11/2004
11/24/2004CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004CN1549802A Process of removing contaminants from an olefin stream using extractive distillation
11/24/2004CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004CN1548412A 3,7-disubstituted trans-dicyclo[3,3,0] octane compound and its prepn and use
11/24/2004CN1548411A Separation method of dimethyl ether prepared with synthetic gas through one-step process
11/24/2004CN1176885C C13 alcohol mixture and functionalized C13 alcohol mixture
11/24/2004CN1176742C Dual-function catalyst for preparing dimethylether directly from synthetic gas and its preparing process
11/23/2004US6822125 Selective removal of water vapor generated by dehydration and cetherification of methanol; catalysis
11/23/2004US6822114 Alkylating p-halo-o-hydrocarbyloxyphenol with monohaloalkane; carbonylation with carbon monoxide to obtain 3,4-disubstituted benzoyl compound; etherification
11/23/2004US6822009 Contact a decomposition material which decomposes the waste cured resins having a oxazolidone, urethane, amino or ester bond to eliminate the crosslinker and 3-dimensional structure and form a vinyl group; reuse
11/23/2004US6821783 Transition metal complexes as linkers
11/23/2004US6821308 Polyoxyalkylene monoethers with reduced water affinity
11/23/2004CA2070595C Process for isomerizing linear olefins to isoolefins
11/18/2004WO2004099221A2 Reactive diluents
11/18/2004WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
11/18/2004US20040230081 Process to produce enantiomerically enriched alcohols and amines
11/18/2004US20040230080 Economical reductive hydrogenation of carboxylic or ketonic end group with hydrogen and carbon supported ruthenium or rhenium metal catalyst
11/18/2004DE10319242A1 Ausgangsverbindungen für die Herstellung von Polyurethanen Starting compounds for the preparation of polyurethanes
11/18/2004CA2521629A1 Reactive diluents
11/17/2004EP1477509A1 Preparation of perfluoropolyethers having at least one -CH2OH or -CH(CF3)OH end group
11/17/2004CN1546448A Method for gas catalytic synthesis of para-methyl methyl phenate
11/17/2004CN1546447A Method for gas-phase synthesis of meta-methyl methyl phenate
11/17/2004CN1546446A Fluorene derivatives and their application
11/17/2004CN1176056C Synthesis process of alkoxy phenol and its analogues
11/17/2004CN1176055C Process for producing 4-methoxyl methyl-2,3,5,6-tetrafluorobenzenemethanol
11/15/2004CA2467152A1 Preparation of perfluoropolyethers having at least one -ch2oh or -ch(cf3) oh end group
11/11/2004WO2004097525A1 Photoresist composition and, used in the photoresist composition, low-molecular compound and high-molecular compound
11/11/2004WO2004096866A2 Processes for recovering oligomers of glycols and polymerization catalyst from waste streams
11/11/2004WO2004096746A1 Initial compounds for producing polyurethanes
11/11/2004WO2004096742A1 Hydroanthracene based compounds as anticancer agents
11/11/2004WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004US20040225160 Process for functionalizing a double bond
11/11/2004US20040225159 Fluorine-containing cyclic compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers resist compositions and patterning method
11/11/2004US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004US20040225121 Labeling using deuterium, tritium with catalyst
11/11/2004US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004US20040224929 Novel vitamin D analogs
11/11/2004US20040224902 Process for obtaining lignans
11/11/2004CA2523019A1 Hydroanthracene based compounds as anticancer agents
11/10/2004EP1475363A1 Method for stabilizing reduced coenzyme q 10 and composition therefor
11/10/2004EP1474369A1 Method for production of a liquid composition of an ortho-dihydroxybenzyl compound of high purity and said composition
11/10/2004EP1406852B1 Method for telomerizing non-cyclic olefins
11/10/2004EP1385811B1 Process for the production of fluoromethyl hexafluoroisopropyl ether
11/10/2004EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004CN1545530A Process for purification of crude polyether and adsorbent
11/10/2004CN1544406A Ethylene glycol diarylether preparation method
11/09/2004US6815530 End group modified polyoxyethylene glycol
11/09/2004US6814960 Prepared in a solid-phase synthesis using a trityl resin
11/04/2004WO2004094355A2 Selective dimethylether recovery and recycle in a methanol-to-olefin process
11/04/2004WO2004094351A2 Novel high metal content intermediates
11/04/2004US20040220409 Reacting 4-fluoro-1-bromobenzene (VI) with 2,2,2-trifluoroethanol in the presence of a base and a copper-containing catalyst
11/04/2004US20040220197 Hydroanthracene based compounds as anticancer agents
11/04/2004US20040219350 Fluorinated polyethers as nonionic surfactants, foam control agents, and/or rheology modifiers
11/03/2004EP1473275A1 Metallized mesoporous silicate and method of oxidation with the same
11/03/2004EP1226105A4 Method for preparing chiral ester
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543449A Solvents containing cycloalkyl alkyl ethers and process for production of the ethers
11/03/2004CN1541993A Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds
11/03/2004CN1174016C Conjugated polymers containing special fluorene structural elements with improved properties
11/03/2004CN1173912C Difluoroxymethane derivative and liquid crystal combination
11/02/2004US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004WO2004092106A2 Process for preparing alkoxy- and aryloxy-phenols
10/28/2004WO2004092105A1 Novel uv-curable perfluorinated, multifunctionalized acrylates monomers, copolyacrylates and their synthetic methods for photonic devices
10/28/2004WO2004092104A1 Process for producing 2-(l-menthoxy)ethanol compound
10/28/2004US20040215043 Selective dimethylether recover and recycle in a methanol-to-olefin process
10/28/2004US20040215040 crystallization in solvent selected from hydrocarbons, fatty acid esters, ethers and nitrites; for use in foods, nutritional supplements, nutrients, drinks, feeds, animal drugs, cosmetics, medicines, remedies, and preventive drugs; oxidation resistance
10/28/2004US20040214989 solid phase peptide biosynthesis and isolation; in vitro translation
10/28/2004US20040214301 Method of producing reduced coenzyme q10crystals with excellent handling properties
10/28/2004US20040214103 norbornene derivative for a chemically amplifying type photoresist for F2 laser, possesses excellent transparency and improved dry etching resistivity, has a fluorine-containing ketone unit or fluorine-containing tertiary alcohol unit directly bonded to the norbornene backbone
10/28/2004US20040214102 Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions
10/28/2004US20040213836 DRUG DELIVERY; prolonging the time a pharmaceutical drug circulates in the blood of a subject, comprising: introducing into the subject's bloodstream a pharmaceutical composition comprising a liposome containing inventive compound
10/28/2004US20040211729 Processes for recovering oligomers of glycols and polymerization catalysts from waste streams
10/27/2004EP1471045A1 Process for producing fluorene derivative
10/27/2004EP1470208A2 Alkylglycol alkoxylates or alkyldiglycol alkoxylates, mixtures thereof with tensides and their use
10/27/2004EP1470105A1 Liquid crystal compounds
10/27/2004EP1470097A1 Pentabromobenzyl alkyl ethers and their use as fire retardants
10/27/2004EP1470094A1 Method for producing toluol derivatives
10/27/2004CN1541197A Method for telomerizing non-cyclic olefins
10/27/2004CN1539805A Method for synthesizing pterostilbene
10/27/2004CN1172893C Integrated technology process for preparing dimethyl ether by synthetic gas
10/27/2004CN1172892C Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004US20040210076 Carene epoxide intermediate that has been used as a precursor to tetrahydrocannabinoids
10/21/2004US20040209931 Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
10/21/2004US20040209202 Fluorinated oxyvinyl compounds
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/20/2004EP1468988A1 Process of preparing disubstituted 9-alkylidenefluorenes and derivatives thereof
10/20/2004EP1467959A1 Acetals of 2,4,7-decatrienal as perfuming or flavoring ingredients
10/20/2004EP1268381A4 Production of fluormethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
10/20/2004CN1538965A Fungicidal 1-benzoxepin derivatives
10/20/2004CN1537839A Continuous reaction rectifying synthesizing methylene diethyl ether technology
10/20/2004CN1537838A Method for synthesis of taxanes
10/19/2004US6806395 For producing 3,5- diisopropylphenol or a similar compound, which serves as an intermediate for producing anti-inflammatory agents, pesticides, etc.
10/19/2004US6806392 Process and manufacturing equipment for preparing acetals and ketals
10/19/2004CA2247044C Addition of amine to improve paraformaldehyde
10/14/2004WO2004087061A2 Tubulin binding agents and corresponding prodrug constructs
10/14/2004WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca)
10/14/2004US20040204615 A dehalogenation reaction is carried out at halogen atoms other than fluorine atoms in at least one chloroperfluroalkenyl perfluorovinyl ether compound, then cyclopolymerization of perfluorinated diene compound
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions